Dan Cao

4.9k total citations · 1 hit paper
165 papers, 3.5k citations indexed

About

Dan Cao is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dan Cao has authored 165 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 42 papers in Molecular Biology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dan Cao's work include Pancreatic and Hepatic Oncology Research (14 papers), Neuroendocrine Tumor Research Advances (12 papers) and Global Health Care Issues (12 papers). Dan Cao is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Neuroendocrine Tumor Research Advances (12 papers) and Global Health Care Issues (12 papers). Dan Cao collaborates with scholars based in China, United States and Australia. Dan Cao's co-authors include Hongyang Wang, Mengchao Wu, Liang Tang, Wen Yang, Hongfeng Gou, Linna Guo, Le‐Xing Yu, Shanhua Tang, Ming Jiang and Tian Fang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Dan Cao

158 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer

2018 779 citations Dan Cao et al. profile →

Peers

Countries citing papers authored by Dan Cao

Since Specialization

Citations

This map shows the geographic impact of Dan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Cao more than expected).

Fields of papers citing papers by Dan Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Cao. The network helps show where Dan Cao may publish in the future.

Co-authorship network of co-authors of Dan Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Cao. A scholar is included among the top collaborators of Dan Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Cao. Dan Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Augmenter of liver regeneration (ALR) can regulate iron homeostasis through the INOS/NO/SLC39A14 pathway to reduce ferroptosis in acute kidney injury 2025 ·FEBS Journal ·(unknown), Dan Cao, (unknown), (unknown), (unknown), Zheng Zhang, (unknown)	0
2	Thoracic dorsal root ganglia: visualisation of normal anatomy and pathological findings by T2 fast field echo (T2 FFE) compared with balanced fast field echo (B_FFE) and nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (SHINKEI) 2025 ·Clinical Radiology ·Yu Yan, Dejun She, Hong Jiang, (unknown), Huapin Huang, (unknown), (unknown), Xueyan Zhao, Hong Jiang, Dan Cao	0
3	Effect of previous caesarean section on reproductive and pregnancy outcomes after assisted reproductive technology: A systematic review and meta‑analysis 2024 ·Experimental and Therapeutic Medicine ·Dan Cao, Lifen Chen	1
4	Space Charge and Conduction Character of PP/POE Composites Under High Temperature 2024 ·Dan Cao, Zepeng Lv, (unknown), Chenyu Wu, Kai Wu, Yonghong Cheng	0
5	Surufatinib combined with transarterial embolization versus surufatinib monotherapy in patients with liver metastatic neuroendocrine tumors: Study protocol for a prospective, randomized, controlled trial 2024 ·Cancer Medicine ·(unknown), Xiaofen Li, Xin You, Minggang Su, Yuzhi Liu, Nengwen Ke, Dan Cao	1
6	Med23 deficiency reprograms the tumor microenvironment to promote lung tumorigenesis 2024 ·British Journal of Cancer ·(unknown), Siming Liu, Dan Cao, Chonghui Li, Hongbin Ji, Gang Wang	7
7	Pharmacogenomics education in China and the United States: advancing personalized medicine 2024 ·Personalized Medicine ·(unknown), Shusen Sun, Wei Zhang, Dan Cao, (unknown)	0
8	Loss of nephric augmenter of liver regeneration facilitates acute kidney injury via ACSL4‐mediated ferroptosis 2023 ·Journal of Cellular and Molecular Medicine ·Lili Huang, Ling Zhang, Zheng Zhang, (unknown), (unknown), (unknown), Dan Cao, Lili Deng, Qi Liu, Hang Sun, Bingbing Shen, Xiaohui Liao	11
9	Stuttering as a signal of encephalopathy associated with toripalimab in a pancreatic ductal adenocarcinoma patient: a case report 2023 ·BMC Neurology ·(unknown), Xi Chen, Ke Cheng, (unknown), Dan Cao, (unknown)	0
10	SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer 2023 ·Biomedicines ·Pei Zhang, (unknown), (unknown), Chen Chang, (unknown), (unknown), (unknown), Tinghong Ye, Dan Cao	10
11	Clinical features and outcomes of pediatric intracranial gliomas: results from single center’s 226 cases and corroborated with SEER database 2023 ·Child s Nervous System ·Zirong Chen, (unknown), Junhong Wang, Dan Cao, Yu Xu, (unknown), Feng Wan	4
12	A novel multimodal deep learning model for preoperative prediction of microvascular invasion and outcome in hepatocellular carcinoma 2022 ·European Journal of Surgical Oncology ·(unknown), Qingqing Chen, (unknown), (unknown), Yuanyuan Zhang, Dan Cao, Wei Zhou, Xiao Liang, Yunjun Yang, Lanfen Lin, Hongjie Hu	18
13	Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish 2022 ·Disease Models & Mechanisms ·Xiaolin Ai, Zengpanpan Ye, (unknown), Jian Zhong, Joseph J. Lancman, (unknown), Xiangyu Pan, Yang Yu, (unknown), Xiang Wang, Shi H, (unknown), Yuqin Yao, Dan Cao, Chengjian Zhao	10
14	Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein–Barr Virus-Associated Gastric Cancer 2022 ·Frontiers in Oncology ·(unknown), Ke Cheng, Xiaofen Li, (unknown), (unknown), Jia Li, Chen Chang, Dan Cao	5
15	Olaparib Treatment in a Patient with Advanced Gallbladder Cancer Harboring BRCA1 Mutation 2021 ·OncoTargets and Therapy ·Xiaofen Li, Limin Gao, Meng Qiu, Dan Cao	2
16	Combination of gemcitabine, nab-paclitaxel, and S-1(GAS) as the first-line treatment for patients with locally advanced or advanced pancreatic ductal adenocarcinoma: study protocol for an open-label, single-arm phase I study 2021 ·BMC Cancer ·Chen Chang, Xiaofen Li, Dan Cao	4
17	The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancer 2021 ·International Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Xiaofen Li, Lingyan Zhou, Dan Cao	0
18	Optimum duration of adjuvant trastuzumab in treatment of human epidermal growth factor receptor-2 positive early breast cancer: protocol for a network meta-analysis of randomised controlled trials 2020 ·BMJ Open ·(unknown), Xin Wang, Ye Chen, (unknown), Ting Luo, Dan Cao	1
19	Mediator MED23 regulates inflammatory responses and liver fibrosis 2019 ·PLoS Biology ·Zhichao Wang, Dan Cao, Chonghui Li, Lihua Min, Gang Wang	15
20	Langerhans Cell Histiocytosis on the Vulva: A Case Report and Review of the Literature 2014 ·Ningxia Sun, Dan Cao, (unknown), Li Wen	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact